Reporting owner · Q3 2026 · CIK 2006362

Xu Zhenyu: insider trades.

Xu Zhenyu reported 14 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($589K), across 1 company.

Transactions
14
Purchases (P)
0
Sales (S)
12
Companies
1
Name as filed
Xu Zhenyu

Companies

CompanyRelationshipTransactions
SOPHiA GENETICS SA (SOPH)Officer · Chief Scientific Officer14

Transactions

14 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-14SOPHiA GENETICS SAS4,000$7.88552,887Form 4
2026-08-27SOPHiA GENETICS SAS10,000$8.91556,887Form 4
2026-08-21SOPHiA GENETICS SAS5,408$8.4566,887Form 4
2026-08-20SOPHiA GENETICS SAS4,592$8.41572,295Form 4
2026-08-19SOPHiA GENETICS SAS10,000$7.94576,887Form 4
2026-08-13SOPHiA GENETICS SAS4,000$7.52586,887Form 4
2026-08-07SOPHiA GENETICS SAS10,000$7.48590,887Form 4
2026-08-07SOPHiA GENETICS SAS7,000$7.02600,887Form 4
2026-08-07SOPHiA GENETICS SAM7,000$3.28607,887Form 4
2026-08-05SOPHiA GENETICS SAM3,000$3.28603,887Form 4
2026-08-05SOPHiA GENETICS SAS3,000$7600,887Form 4
2026-08-04SOPHiA GENETICS SAS10,000$6.92600,887Form 4
2026-07-13SOPHiA GENETICS SAS4,000$5.7610,887Form 4
2026-07-06SOPHiA GENETICS SAS7,393$5.17614,887Form 4

Questions

What stock did Xu Zhenyu buy or sell?

Xu Zhenyu reported 14 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($589K), across 1 company.

Is Xu Zhenyu the same person as other filers with this name?

This page covers SEC CIK 2006362 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/xu-zhenyu-2006362.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.